Sodium Chloride 0.9% Injection — FDA Drug Shortage

To Be Discontinued — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Sodium Chloride 0.9% Injection (injection) from Hospira, Inc., A Pfizer Company with status To Be Discontinued. The shortage was first posted on Dec 3, 2025.

Shortage details

Status
To Be Discontinued
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-7101-67
Dosage Form
Injection
Presentation
Sodium Chloride 0.9%, Injection, 100 mL ADD-Vantage® Flexible Container (NDC 0409-7101-67)
Initial Posting
Dec 3, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.